159 related articles for article (PubMed ID: 17929166)
41. ARK5 is associated with the invasive and metastatic potential of human breast cancer cells.
Chang XZ; Yu J; Liu HY; Dong RH; Cao XC
J Cancer Res Clin Oncol; 2012 Feb; 138(2):247-54. PubMed ID: 22105900
[TBL] [Abstract][Full Text] [Related]
42. The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro.
Hao C; Wei S; Tong Z; Li S; Shi Y; Wang X; Zhu ZH
Tumour Biol; 2012 Aug; 33(4):1159-67. PubMed ID: 22373584
[TBL] [Abstract][Full Text] [Related]
43. Invading basement membrane matrix is sufficient for MDA-MB-231 breast cancer cells to develop a stable in vivo metastatic phenotype.
Abdelkarim M; Vintonenko N; Starzec A; Robles A; Aubert J; Martin ML; Mourah S; Podgorniak MP; Rodrigues-Ferreira S; Nahmias C; Couraud PO; Doliger C; Sainte-Catherine O; Peyri N; Chen L; Mariau J; Etienne M; Perret GY; Crepin M; Poyet JL; Khatib AM; Di Benedetto M
PLoS One; 2011; 6(8):e23334. PubMed ID: 21858074
[TBL] [Abstract][Full Text] [Related]
44. [Effect of TCF21 on proliferation, migration and vascular production of breast cancer cells].
Li PW; Wang HY; Xu LL
Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):307-311. PubMed ID: 30955268
[No Abstract] [Full Text] [Related]
45. B‑cell translocation 1 gene inhibits cellular metastasis‑associated behavior in breast cancer.
Li W; Zou ST; Zhu R; Wan JM; Xu Y; Wu HR
Mol Med Rep; 2014 Jun; 9(6):2374-80. PubMed ID: 24714932
[TBL] [Abstract][Full Text] [Related]
46. Effect of toll-like receptor 3 agonists on the functionality and metastatic properties of breast cancer cell model.
Alizadeh N; Amiri MM; Salek Moghadam A; Zarnani AH; Saadat F; Safavifar F; Berahmeh A; Khorramizadeh MR
Iran J Allergy Asthma Immunol; 2013 May; 12(2):161-7. PubMed ID: 23754355
[TBL] [Abstract][Full Text] [Related]
47. Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs.
Stresing V; Baltziskueta E; Rubio N; Blanco J; Arriba MC; Valls J; Janier M; Clézardin P; Sanz-Pamplona R; Nieva C; Marro M; Petrov D; Sierra A
Oncogene; 2013 Feb; 32(6):724-35. PubMed ID: 22430214
[TBL] [Abstract][Full Text] [Related]
48. Molecular heterogeneity in breast carcinoma cells with increased invasive capacities.
Negro G; Aschenbrenner B; Brezar SK; Cemazar M; Coer A; Gasljevic G; Savic D; Sorokin M; Buzdin A; Callari M; Kvitsaridze I; Jewett A; Vasileva-Slaveva M; Ganswindt U; Skvortsova I; Skvortsov S
Radiol Oncol; 2020 Feb; 54(1):103-118. PubMed ID: 32061169
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of NOTCH-regulated ankyrin repeat protein is associated with breast cancer cell proliferation.
Imaoka T; Okutani T; Daino K; Iizuka D; Nishimura M; Shimada Y
Anticancer Res; 2014 May; 34(5):2165-71. PubMed ID: 24778018
[TBL] [Abstract][Full Text] [Related]
50. Transcriptome analysis and in vivo activity of fluvastatin versus zoledronic acid in a murine breast cancer metastasis model.
Vintonenko N; Jais JP; Kassis N; Abdelkarim M; Perret GY; Lecouvey M; Crepin M; Di Benedetto M
Mol Pharmacol; 2012 Sep; 82(3):521-8. PubMed ID: 22723339
[TBL] [Abstract][Full Text] [Related]
51. Biological influence of brain-derived neurotrophic factor on breast cancer cells.
Yang X; Martin TA; Jiang WG
Int J Oncol; 2012 Oct; 41(4):1541-6. PubMed ID: 22895657
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer.
Yi J; Gao R; Chen Y; Yang Z; Han P; Zhang H; Dou Y; Liu W; Wang W; Du G; Xu Y; Wang J
Oncotarget; 2017 Mar; 8(13):20751-20765. PubMed ID: 27447970
[TBL] [Abstract][Full Text] [Related]
53. Subtype-specific accumulation of intracellular zinc pools is associated with the malignant phenotype in breast cancer.
Chandler P; Kochupurakkal BS; Alam S; Richardson AL; Soybel DI; Kelleher SL
Mol Cancer; 2016 Jan; 15():2. PubMed ID: 26728511
[TBL] [Abstract][Full Text] [Related]
54. Increased metastasis with loss of E2F2 in Myc-driven tumors.
Yuwanita I; Barnes D; Monterey MD; O'Reilly S; Andrechek ER
Oncotarget; 2015 Nov; 6(35):38210-24. PubMed ID: 26474282
[TBL] [Abstract][Full Text] [Related]
55. Bioengineering embryonic stem cell microenvironments for exploring inhibitory effects on metastatic breast cancer cells.
Raof NA; Raja WK; Castracane J; Xie Y
Biomaterials; 2011 Jun; 32(17):4130-9. PubMed ID: 21411140
[TBL] [Abstract][Full Text] [Related]
56. Gene expression profiles in 3D tumor analogs indicate compressive strain differentially enhances metastatic potential.
Demou ZN
Ann Biomed Eng; 2010 Nov; 38(11):3509-20. PubMed ID: 20559731
[TBL] [Abstract][Full Text] [Related]
57. A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo.
Amaro A; Angelini G; Mirisola V; Esposito AI; Reverberi D; Matis S; Maffei M; Giaretti W; Viale M; Gangemi R; Emionite L; Astigiano S; Cilli M; Bachmeier BE; Killian PH; Albini A; Pfeffer U
Oncotarget; 2016 Oct; 7(42):68803-68820. PubMed ID: 27626697
[TBL] [Abstract][Full Text] [Related]
58. Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells.
Grismayer B; Sölch S; Seubert B; Kirchner T; Schäfer S; Baretton G; Schmitt M; Luther T; Krüger A; Kotzsch M; Magdolen V
Mol Cancer; 2012 Aug; 11():62. PubMed ID: 22920728
[TBL] [Abstract][Full Text] [Related]
59. Suppression of the invasion and migration of cancer cells by SERPINB family genes and their derived peptides.
Chou RH; Wen HC; Liang WG; Lin SC; Yuan HW; Wu CW; Chang WS
Oncol Rep; 2012 Jan; 27(1):238-45. PubMed ID: 21993616
[TBL] [Abstract][Full Text] [Related]
60. Role of Carboxypeptidase N Invasion and Migration in Breast Cancer.
Cui R; Zhang P; Li Y
Anticancer Agents Med Chem; 2016; 16(9):1198-202. PubMed ID: 26860443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
